Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway

Author:

Wang XiaoChun1,Li XiaoLi1,Ma XueNi1,Zhang LuDan1,Han TiYun2,Zhang DeKui2

Affiliation:

1. The Second Clinical Medical College of Lanzhou University

2. Lanzhou University Second Hospital

Abstract

Abstract Objective: Intestinal fibrosis is a common complication of inflammatory bowel disease and is characterized by tissue stiffening and luminal narrowing. Dihydromyricetin (DHM) can alleviate liver fibrosis and renal interstitial fibrosis by inducing autophagy. However, whether DHM can alleviate intestinal fibrosis remains unclear. This study aimed to evaluate the role and mechanism of action of DHM in inflammatory bowel disease-associated intestinal fibrosis . Methods: Mice were administered Dextran sulphate Sodium (DSS) in drinking water to induce inflammatory bowel disease-associated intestinal fibrosis. HE staining, qPCR and Western blotting were used to analyze colon inflammation. Masson’ s trichrome staining, qPCR, Western blotting and immunofluorescence staining were used to evaluate the severity of fibrosis. Transmission electron microscopy and Western blotting were used to assess the activation of autophagosomes. The human colonic fibroblast line CCD-18Co, was cultured in the presence of TGF-β1 to develop a fibrotic phenotype.Immunofluorescence staining, Western blotting and qPCR were used to assess the alteration of fibrosis markers and used to investigate whether DHM-induced autophagy was involved in the inactivation of CCD-18Co cells. Additionally, the role of the PI3K/AKT/mTOR pathway was investigated. Results: DHM alleviated intestinal inflammation and inhibited the progression of intestinal fibrosis. Additionally, DHM induced the activation of autophagy, thereby alleviating intestinal fibrosis, and downregulated the PI3K/AKT/mTOR signaling pathway in vitro. Conclusions: Overall, this study demonstrated that DHM can inhibit the progression of intestinal fibrosis and activation of colonic fibroblasts by inducing autophagy through the PI3K/AKT/mTOR signaling pathway, thereby playing a preventive and therapeutic role in intestinal fibrosis.

Publisher

Research Square Platform LLC

Reference44 articles.

1. Inflammatory Bowel Disease;Shapiro JM;Pediatr Rev,2016

2. IBD: cathelicidin can reverse intestinal fibrosis in models of colitis;Leake I;Nat Rev Gastroenterol Hepatol,2015

3. BCL2 Regulates Differentiation of Intestinal Fibroblasts;Weder B;Inflamm Bowel Dis,2018

4. Cellular and molecular mechanisms of intestinal fibrosis;Speca S;World J Gastroenterol,2012

5. Intestinal fibrosis in IBD–a dynamic, multifactorial process;Rieder F;Nat Rev Gastroenterol Hepatol,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3